[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-OCS":3,"homepage-market-summary":29,"stock-news-OCS":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"OCS","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"Oculis Holding AG Ordinary shares","Nasdaq",null,"Common Stock","Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.","67",false,{"close":15,"open":16,"high":16,"low":17,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},8.5,8.83,8.35,8.72,-0.22,-2.52,173680.056151,3433,8.5204,34.475,8.3,353701.36153319443,0.8,1354,{"status":30,"indices":31,"watchlist":76,"sectors":98,"benchmarks":154},"success",[32,41,48,55,62,69],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":40},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0","2026-10-06",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":38,"sparkline":47,"date":40},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":38,"sparkline":54,"date":40},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":38,"sparkline":61,"date":40},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":13,"sparkline":68,"date":40},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":13,"sparkline":75,"date":40},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":13,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":38,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":13,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":13},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":13},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":38},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":13},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":13},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":13},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":13},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":13},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":142,"price":143,"is_up":13},"Real Estate","XLRE",-1.29,40.57,{"name":145,"etf":146,"change":147,"price":148,"is_up":13},"Utilities","XLU",-0.02,41.15,{"name":150,"etf":151,"change":152,"price":153,"is_up":13},"Comm Services","XLC",-0.35,111.26,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":13},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":161,"name":162,"price":163,"change":164,"is_up":13},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":166,"name":167,"price":168,"change":169,"is_up":13},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":171,"name":172,"price":173,"change":142,"is_up":13},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":175,"articles":176},20,[177,183,189,195,200,206,212,218,224,230,235,241,247,253,258,263,268,273,278,284],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"OCS: Oculis Holding AG Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE9ZZXpwSjBuYlBfS3dZbnkzSlQ3a2lEZVZGMUl6VWVBczQzbndlcVlWVUVGZmxOTktfMGd0bEZ1ai1XWW5wNlhqUQ?oc=5","Fri, 02 Oct 2026 15:41:08 GMT","OCS: Oculis Holding AG Latest Stock Price, Analysis, News and Trading Ideas Stocktwits","Stocktwits",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"After Plunging 24% in 4 Weeks, Here's Why the Trend Might Reverse for Oculis Holding AG (OCS) - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxPOWZPRUFlNHNPcGMyWTVrX1N4T0xZR3JKY0NVM2NkdmFtZVNzcm51Qm9Zb2YwWTlDeGtaNnVIajk1UzNfZUExc1MzY2plZWxKZ2JLWnFJN0tjZkZvaTNsb3Bfb2pjMWJjZmVFZm5mNkZDb3NnYzU1aVJCcjA2RkJQOWxBbjdlMnJmLTdpSHZHU3BSb094?oc=5","Mon, 28 Sep 2026 07:00:00 GMT","After Plunging 24% in 4 Weeks, Here's Why the Trend Might Reverse for Oculis Holding AG (OCS) Yahoo Finance","Yahoo Finance",{"title":190,"link":191,"pubDate":192,"description":193,"source":194},"Trial results for a potential dry eye drug are on track for around year-end, Oculis says. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxPeVlHY3FfNml0WTdveXdhSjZTaTUxbzFIcXlDTjMtRlNEN19TR2psQ2VZaTZXVnYzOENsX2phT25iY3hfQ2VxVG1ST1RuN3pXWGdEUjVkb1FGVWJaMVBZVUxsTXhMTUhaaVh6aFdRVlg0MFd3VkREdDVQenQ5eFY5THhjZXRiOU92akJ5SFFSNWJKY3VEbm5QWmRIUm4xSHhsRV9KV3FReUIwYnJKM2RUV21WXzlOdw?oc=5","Wed, 07 Oct 2026 06:00:07 GMT","Trial results for a potential dry eye drug are on track for around year-end, Oculis says. Stock Titan","Stock Titan",{"title":196,"link":197,"pubDate":186,"description":198,"source":199},"Citi Sees $11 Billion Optical Networking Boom Driven By Google, Nvidia - Investor's Business Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxQWFhpNXZhbGxMY2U4S192MzVKbjJ2bjRGVTlubTlXOVp2M2NZYzNaaW9Mazl6Qy1IRndTVnEyYTNNS3VmZVotQjZuTEUtcVJ0SnYzak0zQUZHX0JCQ2R6Ym04LWk0eDZPdWlPRExYR0VySlFjMG9tLWhMWU1iT0VuVzI3NEcyV1BGX0R4ZTctc1BOcl9vaU96YmRKWTdkcUZZY2c?oc=5","Citi Sees $11 Billion Optical Networking Boom Driven By Google, Nvidia Investor's Business Daily","Investor's Business Daily",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Companies Like Oculis Holding (NASDAQ:OCS) Are In A Position To Invest In Growth - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","Companies Like Oculis Holding (NASDAQ:OCS) Are In A Position To Invest In Growth Simply Wall Street","Simply Wall Street",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"(OCS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxPTGdSTklPdUtHcGhGT21sY1UyOXRvVG4zZzBscmVrMWFUWkcxaVhULVdMcElRWU13UG43QnhZdG4ydHEzMWpma19nYkFtSlZLank3bFlIanBKZE5kUkMzNmkzQ1dfSzd1RGthU0NDRWlqYXpkWmt5Tjd3S3VSMFFfUXRjTW9abmVPdXptcEYwYzdxalBDRl9lR21ZamlwbXRsbDA2LWJtVGIxS2FwenhmQ00wanV3NDNDR1FWcW04cmxOeXpWaTdzTDhn?oc=5","Fri, 25 Sep 2026 07:32:02 GMT","(OCS) Price Dynamics and Execution-Aware Positioning Stock Traders Daily","Stock Traders Daily",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Oculis Holding AG Stock 12‑Month Price Target Cut to $36.33, Implies 317% Upside - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxNRjFfWU5nNG9CTWRNdXpybW5GVEVkS05jSElPUGo0YXo1b201d196bnZiY045N1l2UmE0NHBGQTJyblJJMEx0d2VIS2xVaU0xWFRhdU5UaXVORWFCM3BxWFpacVM1czdQeVJlMVhadGNIdnVRT1pFUGVwb2NHdWlsaG42NUlHdTlRX2JULWZXdWFQT01sdVpYdkdUaVExSE9xdk0xVXhyV0pzYTVPUUlxZ3BSZ1FSMGxqV3Q1V1c4LXNpNGw4eW1SZlFEQ3pVSnoxQjBFb1NB?oc=5","Wed, 07 Oct 2026 07:20:05 GMT","Oculis Holding AG Stock 12‑Month Price Target Cut to $36.33, Implies 317% Upside TradingView","TradingView",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Oculis to Present Licaminlimab Precision Medicine Data at AAO 2026 Ahead of Year-End PREDICT-1 Readout - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxNbTg3VmJONXFOOHVxd0ktWWNfQXl6dzJRZTBiYU9GLUc3VDVvRm5NQ2Fhd2x1QmNNNTJNRHFyOHRkYTlQMVE1WUk4UmtOclhPUmk0MHhfa3g3b1JLMy1oNFJ3WExRbDBYVHNEY2o4MmpqOXhLOFZ1d25WOGc1ckNyaDdyX3VuenVnUGh0TGxOaDhrTEJTOVo5bzQwUHRTUFY0R2tscHh1UzFmYm1sMm5VRkZmMVhoenM4cnRyb3A4LUpLbU42aF9nc1A5WGd0blhY?oc=5","Wed, 07 Oct 2026 06:10:00 GMT","Oculis to Present Licaminlimab Precision Medicine Data at AAO 2026 Ahead of Year-End PREDICT-1 Readout Quiver Quantitative","Quiver Quantitative",{"title":225,"link":226,"pubDate":227,"description":228,"source":229},"Lumentum’s $40 EPS Bet Changes Everything (NASDAQ:LITE) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihgFBVV95cUxOV3BibzZNZkVPaWpPSVZ1Zml6djZUUzFiQVZVNWtlNHgtTWlZc2YxaE9mV2REOXJjaGhwei0tT1NTYmNXc2xnSVU1aHB5ZEpqRFMtQTlxWHdmUWU5eXlZbjJWNUsxellyYkJRR19EVUJneDJOdGxNRndiaDA0MWlzUWFDMUFJUQ?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Lumentum’s $40 EPS Bet Changes Everything (NASDAQ:LITE) Seeking Alpha","Seeking Alpha",{"title":231,"link":232,"pubDate":233,"description":234,"source":194},"A five-year multiple sclerosis campaign aims to accelerate research and improve care; Oculis will focus on vision. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPUGZvMm95cGdXc19uTUVmeHBhRUFwdFF4SUd3cU5Rdm1xdXZZQ1ZPQTZJNHA5NjA2Wk9ETUFDMm91a3IxdDc3V0VTMVhuZ1F0N0RoS2NsYXRCZ2xsTkc0emxFY2VPTi1YN1JFZk5idl8wd01JdjVTZGw0aEI2OW9lZDNVdE0wdnJpQktYdERzZUJFQm9CNkxwcHFoUTYxTE5PN19QNl9fQ0Z6NTYyMVo5Zk9JbEdaZDNsZkpuOA?oc=5","Thu, 01 Oct 2026 06:02:54 GMT","A five-year multiple sclerosis campaign aims to accelerate research and improve care; Oculis will focus on vision. Stock Titan",{"title":236,"link":237,"pubDate":238,"description":239,"source":240},"Stifel reiterates Buy rating on Oculis stock, $40 target - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxQd0FZUmk0NFFnRWF5NEJfRHQ1ME4xWWRVLVBLbjFOY0V0Q3A1N3lkY1lCSC1zbFpTZUZoRU1LaVBCZnZPRjF2UDdwYl85V2h2R1NPLW9IZlF2bUIxanBXeHJJbGVxRUx4LTNPSWg0WmY0eVp4bXg0TWpacnJPOHFRZjFLSkxQRmkwTFVteVBmcTh2TkhxNFVEN25nSFVfSFU3NDFHbWEtVnllczMxNm8yMUZZVVA?oc=5","Mon, 28 Sep 2026 13:06:51 GMT","Stifel reiterates Buy rating on Oculis stock, $40 target Investing.com","Investing.com",{"title":242,"link":243,"pubDate":244,"description":245,"source":246},"An enthusiast has created an adapter for three Noctua RTX 5080 Gaming OCs instead of the stock shroud. - GameGPU","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNb0VIX3R0ZldYekRneHlRVlVjSlF6QjhfTWhHVkduZjNKemFrLXp6SlJwWUlkaHdoWFIxOE0wNGZlbzBHc1ZZRHVqYmhpN3MyQ2FqbmVyYTdncXFMSENtZ1NyaEpCMGlkdWkxY3l6alRUcHJkMmRZUUpEWEY5ZnpvcVJDRGRraXo0cjQwQ1I2TGpiQzJhQ2VwMWgteHdQcmpOaE1SZlVINi1lNy1WYUJIV2lyejJTNVNYZHNuTkk1NkxlZkdp?oc=5","Wed, 07 Oct 2026 18:45:24 GMT","An enthusiast has created an adapter for three Noctua RTX 5080 Gaming OCs instead of the stock shroud. GameGPU","GameGPU",{"title":248,"link":249,"pubDate":250,"description":251,"source":252},"Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxPQS01NHZqY01ZOVFmVkdYN3dCMTRTZnNPUmVKWDRQN1NfWkktNmFfZDJkcXNPbV9zdVd3YS1wREZyd3d4VG1hTDV0aWMtRF9iNlhyQkcxSGtVR2taTTktbERscTMyeGE2NXJTSmduT0hsS3p3TWhBOVlkNVRfajl1REgxLXAxNGJlTTNpRHI0bzhVR0F3amVPUy1TWDZFYnlUemhLWC1NNlVZclYzcHpEb281VHFWYnpMVEE?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy Benzinga","Benzinga",{"title":254,"link":255,"pubDate":256,"description":257,"source":223},"Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS as Vision Industry Partner - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxNY3BmTnQwTHFqMDN4WmJmcUxCWXJ3OWFjYlMzZnZ5UzdQZjBlWFk4RmE4QVRXN1dlSk9yMDhIanF1d3hUUXFDYVI0dFdTazdZSS1tYlB4MGZaYmNacVZkMWVoaGd0Mzd2dnNTQWIwMFFkQW1SVjB0YUU1N1g2SFRydGNMQXFPZzZxeFo1OWlMcXQzcS12UnNkblh0WEZSdTBMZEl5aDN1X1Z4aFJRVzNsdklGSnRNNElqUlpEYkNtOWZ2dFNxVnlVOEZwTVk1ZDlGMG9MMmFqZ2Y?oc=5","Thu, 01 Oct 2026 06:10:00 GMT","Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS as Vision Industry Partner Quiver Quantitative",{"title":259,"link":260,"pubDate":261,"description":262,"source":229},"Lumentum: The Rally May Not Be Over (NASDAQ:LITE) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMigAFBVV95cUxNY1U5RWdPcGRqV3Z6YkxmcEFRRTJVWjlUWUpJMUhJOF9adFdqYU1HYXkzTnVTekpOLTZydFF1bUo4Ykg3eHZYSmxkb2hpUzAwb2p4a2VhVkg1blYtNlpHalNQT0JfcHdUdldqNnFzQ3J0cHpsWTR0ZWt1cVU5d1RSdA?oc=5","Sat, 03 Oct 2026 15:39:25 GMT","Lumentum: The Rally May Not Be Over (NASDAQ:LITE) Seeking Alpha",{"title":264,"link":265,"pubDate":266,"description":267,"source":194},"Eight directors remain at Oculis (OCS) after a board member serving since 2017 resigns. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxPMkl5b3JWMjB2M1lGNVNTZl9USWljU0tQVGduOFdPRENZWHo5bUxmMDZ3aTNiOUtYTmpvSm1lanVLU0NMQm03U0RxUXZHMHFvV3JVWVJfMTlMM2xqQmlYRWFIUFkwb0xRZ0R4dERfZUwwZnhsX0dsY3Z1NXNROG95dWR5YTRwc1Z2VUg2cUZhZUpLbDN3OTc5ZzJnRWkwNVYtX0Z0Z3JDaXZuX1QwQWFpU3Rn?oc=5","Wed, 30 Sep 2026 21:03:00 GMT","Eight directors remain at Oculis (OCS) after a board member serving since 2017 resigns. Stock Titan",{"title":269,"link":270,"pubDate":271,"description":272,"source":194},"Six employees can buy Crescent shares for $13.94 each once their options vest. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxQOW0wRzZpUWZwbWxYcjZIVzR5TkNoTjh0WHRKWGVyY3lQc3B0UE5ieU44SDF1alVmZkhPeUJhSHhVMWxhQW9Fanh1Q2tGNmZBXzFqeGpKN2VsVmMzZm1MQ1ZGM3BYdHh2TW1raGV3YlpzM3VISFZIenBnSHU1YzliZFBzcVgyMjB1RmFWTzVQcG85NXF1c2pZUGpWX25xWE1MTFZ6b0M0VQ?oc=5","Tue, 06 Oct 2026 20:15:00 GMT","Six employees can buy Crescent shares for $13.94 each once their options vest. Stock Titan",{"title":274,"link":275,"pubDate":276,"description":277,"source":194},"Software that maps the heart’s electrical activity gets FDA clearance - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQeXRYQ2RsMUZmemhnYjlIMEg2aVlULUkzMDR4X01mQm1qR3c4OUp5ZmJFWThxNTRFaEI2SmZMSHpTMVMtRHdOQ3RHaXRfNzVEYmdRdF9IaWRDUEExbjFkYUg1Tm9acGYtTDUyVVNBRHo0anNfUER3TWYwUjVEOS1wR3B4dEUyWGxmSUoyQ3lCZXg5TWg5THE5OGxiQmNsOFVkbjY3OVhRdU4wdU9ENkd2Vkl3THNqc28xTzZjajFLTQ?oc=5","Wed, 30 Sep 2026 13:00:00 GMT","Software that maps the heart’s electrical activity gets FDA clearance Stock Titan",{"title":279,"link":280,"pubDate":281,"description":282,"source":283},"Oculis Holding AG (OCS) Climbs 2.30% to $9.34 as Shares Press Toward Resistance - Impulse Wave - https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxNLS11Wk5rSHpXeGs3YkR4bVJ6R09DWUY2c09NQ2xHWmtZNFBJX1pRekxPS2JsVEE5UlB2WUR2WWpnYUhRN3NwYV9SUHJMV3VMcE4tcFZhMVVXaGI3LUNMY0UyNGNsT2Y0eDRXZ2ZPSkJ5MktfZUxJS1V6NVVneVNMeU9vN0RIVF9MTzdMMmhSUjNwQTlqT3FDYWMxTFd4YTdFUmNTQUNMcVlhZkhfVGEweWZNQy1nQXFW?oc=5","Thu, 01 Oct 2026 09:45:04 GMT","Oculis Holding AG (OCS) Climbs 2.30% to $9.34 as Shares Press Toward Resistance - Impulse Wave https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fwww.dars.gov.et\u002F",{"title":285,"link":286,"pubDate":203,"description":287,"source":229},"TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxOYldwdnNaSExDVHFpUHVObDgtNnZFbGZkdkZZUU5ISDdUSzB0V1pBYWtUbU9FMVA2VkcxUlVGMkQwRUpNOWxNd2d2NzYzakFOUVRydV85eDBuOUFpYTRnU0Nqai1HQlFKTlhBWXFEeUlrRmpZd3FOdjRXOWhycURyTzVlYUo1OGlNR2JrM1NKOGlicmxhZXJ6dDNsZWhadHlJOUJ3ZUYwU2R6ZG1JbWxFTW1EYTBoRnZaQ1luU2g0R013UzA?oc=5","TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX) Seeking Alpha"]